Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA regions rich in guanine (G) and cytosine (C) bases, known as GC-rich regions, are segments of the genome with a high proportion of G and C nucleotides. These regions exhibit unique structural properties, biological significance, and play critical roles in gene regulation, particularly through CpG islands and methylation. They also form non-canonical secondary structures like G-quadruplexes and i-motifs, which can influence genomic stability and gene expression. GC-rich DNA is a target for drug development, specifically small molecules designed to bind to G-quadruplexes or i-motif structures. Understanding GC-rich regions is essential for studying genome function and developing targeted therapies.
Varies depending on the specific region and interacting molecule; can involve disruption of secondary structures, modulation of methylation patterns, or interference with protein binding.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA (via guanosine-cytosine-rich regions) (GC-rich DNA).